Evaluation of topical 0.05% mequitazine and 0.05% levocabastine in comparison with 0.1% dexamethasone in the allergen challenge model.

被引：0

|

作者：

Richard, C

Bibas, P

Trinquand, C

机构：

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1999年 / 40卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

4818B621

引用

收藏

页码：S914 / S914

页数：1

相关论文

共 33 条

[21] A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model
Abelson, MB
Kaplan, AP
CLINICAL THERAPEUTICS, 2002, 24 (03) : 445 - 456
[22] CONTROL OF THE BIOAVAILABILITY OF A TOPICAL STEROID - COMPARISON OF DESONIDE CREAMS 0.05-PERCENT AND 0.1-PERCENT BY VASOCONSTRICTOR STUDIES AND CLINICAL-TRIALS
BARRY, BW
FYRAND, O
WOODFORD, R
ULSHAGEN, K
HOGSTAD, G
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (06) : 406 - 409
[23] Comparison of efficacy and safety of topical triamcinolone acetonide paste 0.1% and fluticasone propionate spray 0.05% in the treatment of symptomatic oral lichen planus and their influence on quality of life
Handa, Sanjeev
Kaur, Inderjeet
Joshi, Smita
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB188 - AB188
[24] A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis
Han, Demin
Chen, Lei
Cheng, Lei
Liu, Shixi
Fu, Zheng
Zhang, Wei
Wang, Chengshuo
Xi, Lin
Zhang, Luo
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2011, 73 (05): : 260 - 265
[25] Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model
D'Arienzo, PA
Leonardi, A
Bensch, G
CLINICAL THERAPEUTICS, 2002, 24 (03) : 409 - 416
[26] Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis
Discepola, M
Deschenes, J
Abelson, M
ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 : 43 - 46
[27] Cumulative irritation potentials of combination therapies: A comparison of adapalene gel 0.1%, tazarotene cream 0.05%, and tretinoin microsphere 0.04% when applied in combination with topical antibacterial gels
Dosik, J
Arsonnaud, S
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P22 - P22
[28] Activity of a 0.05% triamcinolone acetonide/laurocapram formulation: Double-blind, randomized comparison with standard 0.1% triamcinolone acetonide creams and with mild (class VI) to potent (class III) topical corticosteroids
Cato, A
Sutton, L
Manning, GN
Kaplan, AS
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (04): : 231 - 235
[29] Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model
Berdy, GJ
Stoppel, JO
Epstein, AB
CLINICAL THERAPEUTICS, 2002, 24 (06) : 918 - 929
[30] Comparison of the topical antihistamine/decongestant, OcuHist(R), versus the oral antihistamine, Claritin(R), in the allergen challenge model of acute allergic conjunctivitis.
McGarr, P
Abelson, MB
Gerolimatos, B
Frisch, S
Neibart, S
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 5028 - 5028

← 1 2 3 4 →